Project Grant R00AA029454

Award Date 9/20/24
Completion Date 8/31/27
Dollars Obligated $510K
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21201, USA
Similar Awards
This $194,400 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will support research on the effects of adolescent alcohol use on the oral microbiome and brain. The awardee, the Medical University of South Carolina, will recruit 126 adolescents (ages 14-18) with varying levels of alcohol use to collect salivary samples to assess the oral microbiome, with a focus on the Lactobacillus...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) provides $184,359 to Virginia Commonwealth University (VCU) to evaluate the use of fecal microbiota transplant (FMT) as a potential therapy to reduce ethanol drinking in mice. The key objectives are to assess the effects of microbiota transplant from human donors with varying amounts of beneficial gut bacteria (Lachnospiraceae and Ruminococcaceae) on...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will support the development and testing of a novel in vivo model called CHIMERA-BONCAT. This model will enable comprehensive, unbiased, and cell-type-specific characterization of the human microglial response to alcohol exposure. The $214,385 award, with a period of performance from August 2024 to July 2026, will fund research...
This Project Grant award of $131,654.00 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) aims to develop a Lactobacillus-vectored alkaline phosphatase (AP) to mitigate alcohol-induced leaky gut and reduce lipopolysaccharide (LPS) endotoxin levels in the gut. The project, awarded to Biomedit LLC, has two key objectives: 1) generating engineered live biotherapeutics (ELBPs) that can deliver functional AP, and 2) evaluating the...
This federal Project Grant award, issued by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), provides $350,000 in funding to Sanford Research North to investigate the biobehavioral mechanisms underlying increased alcohol use following bariatric surgery. The primary objectives are to examine how changes in the gut microbiome and the rewarding effects of alcohol influence the risk of hazardous alcohol use in...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,391,376 to Rutgers, The State University to conduct multidisciplinary research characterizing the gut-brain axis in addiction. The project aims to identify and validate relevant interactions between the gut microbiota, psychostimulant exposure, and vulnerability to substance use disorders. Using metagenomics, metabolomics,...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the federal Alcohol Research Programs (CFDA 93.273), provides $698,356 to Brown University to study the relationship between alcohol-associated gut dysbiosis and cardiovascular disease (CVD) risk in people with HIV. The key objectives are to: 1) characterize alcohol-associated gut dysbiosis using whole genome sequencing of fecal samples; 2) examine how gut microbiome changes at the...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will support the development of novel 3D human brain circuits to investigate the role of microglia in alcohol use disorder (AUD) and Alzheimer's disease (AD) pathology. The $223,531 award to the University of North Carolina at Chapel Hill will fund research to elucidate how alcohol-induced changes in microglial metabolism...
This Project Grant award, funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program, aims to investigate the neural mechanisms driving adaptive stress coping behaviors and subsequent alcohol use. The $498,121.57 award, effective August 15, 2024 through July 31, 2027, will utilize an animal model to explore how dysfunction in the corticolimbic circuitry, specifically the prelimbic cortex and basolateral...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $537,587 Project Grant under the Alcohol Research Programs (CFDA 93.273) to The University of Texas Southwestern Medical Center to conduct research on the metabolic consequences of liver inflammation on alcohol consumption and alcohol-associated liver disease (ALD). The key objectives are to identify the mechanisms by which the transcription factor IRF3 suppresses the expression and secretion of the metabolic regulator...

This Project Grant award of $510,412.27 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund research to investigate the role of the gut microbiota in alcohol seeking and reward-related decision-making. The research will use mouse models and computational modeling to determine if manipulating the gut microbiota, such as through the use of prebiotics, can mitigate alcohol-induced behavioral impairments. The award period runs from Sep 20, 2024 to Aug 31, 2027 and is being provided to the University of Maryland, Baltimore to conduct this research. The goal is to evaluate the potential of the gut microbiota as an alternative treatment target for alcohol use disorders.

Generated 8/5/25, 3:08 AM